BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shih CA, Chen WC. Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy. World J Clin Cases 2021; 9(21): 5769-5781 [PMID: 34368296 DOI: 10.12998/wjcc.v9.i21.5769]
URL: https://www.wjgnet.com/2307-8960/full/v9/i21/5769.htm
Number Citing Articles
Jia-Rui Zheng, Zi-Long Wang, Bo Feng. Hepatitis B functional cure and immune responseFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1075916
Sara Lacerda Pereira, Raquel Duro, António Sarmento. Late Hepatitis B reactivation after treatment with rituximabIDCases 2022; 27: e01393 doi: 10.1016/j.idcr.2022.e01393
Caterina Sagnelli, Antonello Sica, Massimiliano Creta, Alessandra Borsetti, Massimo Ciccozzi, Evangelista Sagnelli. Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19Pathogens 2022; 11(5): 567 doi: 10.3390/pathogens11050567
Serena Zaltron, Anna Cambianica, Marco Di Gregorio, Cosimo Colangelo, Samuele Storti, Giorgio Tiecco, Francesco Castelli, Eugenia Quiros-Roldan. Case report: An occult hepatitis B virus infection reactivation in an HIV/HCV coinfected patient during an immune reconstitution inflammatory syndromeFrontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1143346
Tânia Lourenço, Nuno Vale. Entecavir: A Review and Considerations for Its Application in OncologyPharmaceuticals 2023; 16(11): 1603 doi: 10.3390/ph16111603
Chunyan Yuan, Jing Peng, Renxiang Xia, Jian He, Tianji Qiu, Yunqing Yao. Reactivation of Occult Hepatitis B Virus Infection During Long-Term Entecavir Antiviral TherapyFrontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.865124
Adeniyi Abraham Adesola, Matei-Alexandru Cozma, Yong-Feng Chen, Bahadar Singh Srichawla, Mihnea-Alexandru Găman. Risk of hepatitis B reactivation in patients with myeloproliferative neoplasms treated with ruxolitinibWorld Journal of Hepatology 2023; 15(11): 1188-1195 doi: 10.4254/wjh.v15.i11.1188
Jiajia Hu, Jie Zhao, Chunyan Wang, Mei Jia, Ming Su, Shanshan Li. Epstein–Barr virus reactivation correlates with worse outcomes for patients exposed to hepatitis B virus after haploidentical hematopoietic stem cell transplantationAnnals of Hematology 2023; 102(12): 3593 doi: 10.1007/s00277-023-05492-z
Shahrzad Shoraka, Seyed Reza Mohebbi, Seyed Masoud Hosseini, Amir Ghaemi, Mohammad Reza Zali. SARS-CoV-2 and chronic hepatitis B: Focusing on the possible consequences of co-infectionJournal of Clinical Virology Plus 2023; 3(4): 100167 doi: 10.1016/j.jcvp.2023.100167
Zahra Dossaji, Lubaba Haque, Adam Khattak, Mark Hsu, Robert Gish. A Review of Hepatitis B Reactivation Risk on Immunosuppressants with a Focus on Newer ImmunomodulatorsCurrent Hepatology Reports 2024;  doi: 10.1007/s11901-024-00662-7